US lists India, China, Pakistan in FY2027 drug transit and production determination
The US has named 23 countries, including India, China and Pakistan, as major drug transit or illicit drug-producing states for fiscal 2027.
The United States has named India, China and Pakistan among 23 countries designated as major drug transit or major illicit drug-producing states for fiscal year 2027, in a presidential determination submitted to Congress on September 15.
Washington makes clear that inclusion on the list is not in itself a finding that a government is complicit in drug trafficking. Countries can be listed because geographic, commercial and economic conditions allow drugs or precursor chemicals to be produced or moved through their territory.
India
India appears in the FY2027 determination, as it did in the previous year's list. The document welcomes the efforts of Prime Minister Narendra Modi and the Indian government to tackle illicit opium poppy cultivation and to strengthen supply-chain integrity, and records Washington's expectation of continued cooperation under the US-India Drug Policy Framework.
China
The determination places particular emphasis on China's role in supplying precursor chemicals for illicit synthetic drugs, describing it as the world's largest producer of many such chemicals used in the manufacture of fentanyl, methamphetamine and other synthetic drugs. It calls on Beijing to take further steps, including scheduling additional precursor chemicals and substances requested by the United States.
Pakistan
Pakistan is also listed, but is not among the countries found to have failed demonstrably over the previous 12 months to meet international counternarcotics obligations. Afghanistan, Bolivia, Burma and Colombia are identified separately on that count. The determination states that assistance to Bolivia, Burma and Colombia is vital to US national interests.
The full list comprises Afghanistan, The Bahamas, Belize, Bolivia, Burma, China, Colombia, Costa Rica, the Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, India, Jamaica, Laos, Mexico, Nicaragua, Pakistan, Panama, Peru and Venezuela.
The determination adds that Washington will keep working with partner countries to disrupt trafficking networks, precursor-chemical supplies and illicit drug production.